ACTRN12614001000695已完成未知
Regional citrate anticoagulation for continuous venovenous hemofiltration using Prismocitrate 18/0 and a phosphate containing replacement solution (Phoxilium) for critically ill patients: Effect on filter life and acid-base changes
Intensive Care Unit, Queen Elizabeth Hospital0 个研究点目标入组 50 人开始时间: 2014年9月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 85 Years（—）
- 性别
- All
入选标准
- •All patients who underwent CVVH using Prismocitrate 18/0 and Phoxilium during the study period
排除标准
- •Insufficient data for analysis
研究者
相似试验
招募中
3 期
Regional Citrate Anticoagulation for acute intermittent hemodialysis versus saline flushing for safety, efficacy and effect on prolong life of blood circuit of hemodialysis machine; Randomized controlled trialHypocalcemia,lead to numbness,carpopedal spasm,seizure and arrhythmiaMetabolic alkalosisTCTR20200630004Government300
已完成
不适用
Regional citrate anti-coagulation for continuous renal replacement therapy in patients with acute kidney injuryAcute kidney injuryACTRN12611000099921Department of intensive care, Pamela Youde Nethersole Eastern Hospital10
已完成
不适用
Regional Citrate Anticoagulation for RRT During V-V ECMOARDS, HumanAcute Kidney InjuryNCT05148026University of Milano Bicocca18
已完成
不适用
iver Citrate Anticoagulation Threshold studyISRCTN92716512Fresenius Medical Care (Germany)120
尚未招募
3 期
Efficacy of Regional Citrate Anticoagulation versus SalineFlushingduring Intermittent Hemodialysis on blood circuit clotting prevention;A Randomized Clinical Trialhypocalcemia hypernatremia metabolic alkalosis cardiac arrhythmiaRegional citrate anticoagulants Saline flushing intermittent hemodialysisTCTR20210929007Bhumibol Adulyadej Hospital42